Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and nucleic acid analysis products for use in diagnostic or research applications, as well as instruments and process control products for hematology, blood chemistry, blood gases, and coagulation controls and reagents used in various diagnostic applications.
Bio-Techne Corporation
Unlock to Claim this listing
Add / Modify Company
4.1
Overall Excellence Rating
Industry
HealthcareCategory
Biotech & PharmaceuticalsESG/Ethical Impact
Bio-Techne’s products and services in life sciences and diagnostics might indirectly contribute to environmental sustainability through research that advances understanding of diseases and potential treatments. Energy Efficiency: The company’s operations and facilities could focus on energy-efficient practices to minimize its environmental footprint.Health and Science Advancements: Bio-Techne’s products support scientific research, contributing to advancements in the fields of life sciences, diagnostics, and biotechnology. Research Collaboration: Collaboration with researchers and institutions positively impacts the broader scientific and medical communities.Transparency: Bio-Techne’s commitment to transparency and ethical conduct likely reflects in its corporate governance practices. The company’s ESG initiatives can resonate with investors interested in both financial returns and scientific contributions.Bio-Techne’s financial sustainability comes from its products and services in life sciences, diagnostics, and related fields. Investor Relations: The company’s ESG efforts can influence investor perception, especially for those seeking investments aligned with responsible scientific advancements. Bio-Techne’s products and collaborations support the work of researchers and scientists, positively impacting scientific progress.The company’s products and services are likely used in ethical research endeavors to advance human health and understanding.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
$1,100,000,000.00
Website Traffic
Employee Rating
3.7
Customer Rating
3.2
Company Size
1000-5000
ESG Risk Rating
4